Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors

被引：100
|
作者：
Kwekkeboom, Dik J. [1 ]
Krenning, Eric P. [1 ]
机构：
[1] Univ Med Ctr, Erasmus MC, Dept Nucl Med, NL-3015 CE Rotterdam, Netherlands
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2016年 / 30卷 / 01期
关键词：
Neuroendocrine tumor; Carcinoid; Radionuclide therapy; PRRT; Treatment; RADIOLABELED SOMATOSTATIN ANALOG; PHASE-I; RADIOPEPTIDE LU-177-OCTREOTATE; CARCINOID-SYNDROME; SALVAGE THERAPY; COMBINATION; TOXICITY; SURVIVAL; Y-90-DOTATOC; CAPECITABINE;
D O I：
10.1016/j.hoc.2015.09.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Peptide receptor radionuclide therapy (PRRT) is a promising new treatment modality for inoperable or metastasized gastroenteropancreatic neuroendocrine tumors patients. Most studies report objective response rates in 15% to 35% of patients. Progression-free (PFS) and overall survival (OS) compare favorably with that for somatostatin analogues, chemotherapy, or newer, "targeted" therapies. Prospective, randomized data regarding the potential PFS and OS benefit of PRRT compared with standard therapies is anticipated.
引用
收藏
页码：179 / +
页数：15
相关论文
共 50 条
  • [1] Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Jong, Marion
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    NEUROENDOCRINOLOGY, 2013, 97 (01) : 74 - 85
  • [2] Peptide receptor radionuclide therapy of neuroendocrine tumors
    Haug, A. R.
    Bartenstein, P.
    ONKOLOGE, 2011, 17 (07): : 602 - +
  • [3] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Bodei, Lisa
    Kidd, Mark
    Prasad, Vikas
    Modlin, Irvin M.
    NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 : 198 - 215
  • [4] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Basu, Sandip
    Parghane, Rahul, V
    Kamaldeep
    Chakrabarty, Sudipta
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (05) : 447 - 464
  • [5] Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children
    Foster, Jennifer H.
    Sher, Andrew
    Seghers, Victor
    Poston, Jay
    Wells, Donald
    Delpassand, Ebrahim S.
    Potter, Samara
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [6] Peptide Receptor Radionuclide Therapy An emrirciing treatment for gastrointestinal neuroendocrine tumors
    Myers, Adria
    Chitwood, Holly Renea
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2020, 24 (02) : 129 - 133
  • [7] Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Bodei, Lisa
    Cremonesi, Marta
    Kidd, Mark
    Grana, Chiara M.
    Severi, Stefano
    Modlin, Irvin M.
    Paganelli, Giovanni
    THORACIC SURGERY CLINICS, 2014, 24 (03) : 333 - +
  • [8] Treatment guidelines for pancreatic neuroendocrine tumors (except peptide receptor radionuclide therapy)
    Duval, M.
    Vezzosi, D.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2020, 24 (4-5): : 152 - 156
  • [9] Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
    Starr, Jason S.
    Sonbol, Mohamad Bassam
    Hobday, Timothy J.
    Sharma, Akash
    Kendi, Ayse Tuba
    Halfdanarson, Thorvardur R.
    ONCOTARGETS AND THERAPY, 2020, 13 : 3545 - 3555
  • [10] Joint Guidance on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
    Delbeke, Dominique
    Graham, Michael M.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) : 663 - 663
12345